Cabrina,
I began researching Stratford after reading an article in the November issue of Equities magazine. I found the technology intriguing, and see enormous potential in an extremely large market. I also liked the large profit margin potential. I was also very impressed with the web page that had been developed. However, I was concerned with the large stock price fluctuations that had taken place, so I made contact with Stratford and found out the whole story regarding the history of the company. I was very impressed with Roy McMillian, the new CEO. He brings 30 years of managment experience to the table. Roy accepted the position after the stockholders ousted the prior management. He seems to have the confidence, vision, and experience needed to turn Stratford around. It is too bad that he has to clean up such a mess left behind by the last management. During our discussion, I inquired as to the contents of the web page and the Equities article and their contents. Roy spoke honestly with me, stating that the product claims were true, (he believes that Novacrete is the best product on the market) but there was some embellishment, and some of the information was taken out of context regarding projections and contracts. I believe that this misinformation drove the price skyward, and ultimately caused the downward plunge. After taking over, Roy removed the information from the web page due to the inaccuracies, but plans to start adding information to it once the the new auditor report is complete. I believe he said the new auditing firm was Feldman/Radon. Feldman/Radon specializes in companies that have had problems in the past. From what I gathered from him, the audit was nearing completion. Although he expects the results to be very different that those reported in the past, a truthful audit should be good news for stockholders and the SEC. They've been holding off releasing information until the audit is complete. So the info should start flowing once the audit is released. Roy also mentioned that they should be in production of their product by April. Roy also stated that they just received test results from an additional product that will significantly increase their revenue stream.
I'm not suprised that the stock price has gone from .25 to the .60 -.70 range on much larger than normal volume. The word is getting out that this company, now with a great product and competent management is on the right track. I think the upside to this stock is enormous. Good luck to all.
Mark S. |
